Stock Price Quote for REGN

loading indicator
Live data delayed by 15 minutes

Profile

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Their full address is 777 Old Saw Mill River Road, Tarrytown, New York 10591-6707, United States.

Shares are traded on the Nasdaq exchange under ticker symbol "REGN".

Regeneron Pharmaceuticals operates in the health care/life sciences sector while being primarily involved in the biotechnology industry.

To learn more, visit their official website at regeneron.com.

Investomatica Comment Policy

Discussions are welcome. Please stay on topic and remember to be kind to each other. If you would like to report a bug or issue with one of our pages or calculators, please direct message us on twitter instead.